Is hepatotoxicity in patients treated with gemtuzumabozogamicin due to specific targeting of hepatocytes?
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference10 articles.
1. Gemtuzumab Ozogamicin (CMA-676, Mylotarg) for the treatment of CD33+ acute myeloid leukemia;Voutsadakis;Anticancer Drugs,2002
2. Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse;Sievers;Expert Opin Biol Ther,2001
3. Mylotarg: antibody-targeted chemotherapy comes of age;Sievers;Curr Opin Oncol,2001
4. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia;Bross;Clin Cancer Res,2001
5. Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemia;Arceci;Blood,2005
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. T cell-redirecting therapies in hematological malignancies: Current developments and novel strategies for improved targeting;Molecular Therapy;2024-09
2. Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability;Cancers;2023-01-24
3. Single‐dose (4.5 mg/m 2 ) gemtuzumab ozogamicin in combination with fludarabine, cytarabine and anthracycline as reinduction therapy in relapsed or refractory paediatric acute myeloid leukaemia;British Journal of Haematology;2022-04-19
4. Mechanisms contributing to ado-trastuzumab emtansine-induced toxicities: a gateway to better understanding of ADC-associated toxicities;Antibody Therapeutics;2021-01-01
5. Gemtuzumab Ozogamicin Combined With Intensive Chemotherapy in Patients With Acute Myeloid Leukemia Relapsing After Allogenic Stem Cell Transplantation;Clinical Lymphoma Myeloma and Leukemia;2020-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3